HQL
Tekla Life Sciences Investors
18.20$
+4.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q3 23 | Q4 23 | Q1 24 | Q3 24 | Q1 25 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.0% | +2,739,279.4% | -100.0% | +199,899.1% | +1,432.4% | -93.0% | +0.0% | -7.3% | +850.5% | -36.1% | +313.2% | |
| – | – | – | – | – | -2.4% | -2.3% | +0.0% | +11.6% | -10.6% | -3.3% | +27.5% | |
| – | -100.0% | +2,405,471.3% | -100.0% | +199,899.1% | +1,298.1% | -92.3% | +0.0% | -7.3% | +718.5% | -41.4% | +389.2% | |
| – | -7.6% | +99,900.3% | -99.9% | +199,899.9% | -31.5% | +37.8% | +0.0% | +16.8% | -13.5% | -72.8% | +341.0% | |
| – | -61.5% | +99,901.7% | -99.9% | +17,909.7% | +1,238.7% | -92.9% | +0.0% | +17.0% | +1,877.1% | -296.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -50.8% | |
| – | – | – | – | +199,905.6% | -133.9% | – | +0.0% | -30.3% | -234.8% | – | -50.8% | |
| – | – | – | – | -99.7% | -200.0% | – | -101.3% | – | – | – | – | |
| – | – | – | – | +199,905.6% | -133.9% | – | +0.0% | -30.3% | -234.8% | – | -50.8% | |
| – | – | – | – | +194,494.2% | -133.9% | – | -0.6% | -65.1% | -234.8% | – | -50.8% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.